Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as adjunct to celecoxib in knee osteoarthritis
NCT04767841Phase 2Withdrawn
- Sponsor
- Sadat City University
- Start
- Feb 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in osteoarthritis (OA), sponsored by Sadat City University. Planned start Feb 2021; status: withdrawn.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04767841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04767841.